Geode Capital Management’s TCR2 Therapeutics Inc. Common Stock TCRR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
|
|||||
|
2023
Q1 | $473K | Hold |
|
|||||
|
2022
Q4 | $314K | Sell |
|
|||||
|
2022
Q3 | $569K | Buy |
|
|||||
|
2022
Q2 | $903K | Sell |
|
|||||
|
2022
Q1 | $1.49M | Sell |
|
|||||
|
2021
Q4 | $2.9M | Buy |
|
|||||
|
2021
Q3 | $3.87M | Sell |
|
|||||
|
2021
Q2 | $8.07M | Buy |
|
|||||
|
2021
Q1 | $10.1M | Buy |
|
|||||
|
2020
Q4 | $11.6M | Buy |
|
|||||
|
2020
Q3 | $7.05M | Buy |
|
|||||
|
2020
Q2 | $3.75M | Buy |
|
|||||
|
2020
Q1 | $1.48M | Buy |
|
|||||
|
2019
Q4 | $2.51M | Buy |
|
|||||
|
2019
Q3 | $2.44M | Buy |
|
|||||
|
2019
Q2 | $576K | Buy |
|